FDA Inspection 1137604 — Alcami Carolinas Corporation
The FDA completed an inspection of Alcami Carolinas Corporation on February 18, 2021 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 18, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wilmington, NC (United States)